申请人:A. H. Robins Company, Incorporated
公开号:US04642348A1
公开(公告)日:1987-02-10
Novel pyrrolidine, piperidine and homopiperidinecarboxamide and thiocarboxamide compounds having the formula: ##STR1## wherein X is --S--, --S(O)-- or --S(O).sub.2 --; A is a loweralkalene chain and A.sup.1 and A.sup.2 are alkalene chains when p and d are one; R, R.sup.1 and R.sup.2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R.sup.1 and R.sup.2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts useful as cardiac antiarrhythmia agents are disclosed. Novel chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with --(A.sup.2).sub.p --X--(A.sup.2).sub.d --Q side chain are also disclosed.
新型吡咯烷、哌啶和高哌啶羧酰胺及硫代羧酰胺化合物,具有如下通式:##STR1## 其中X为--S--、--S(O)--或--S(O)2--;A为低级烷撑链,当p和d为一时,A1和A2为烷撑链;R、R1和R2为氢、低级烷基、苯基、环烷基或苯基烷基,且R1和R2可与相邻的氮原子形成杂环残基;Q为选定的芳香基团,并公开了作为心脏抗心律失常剂的药用可接受的酸加成盐。还公开了在吡咯烷、哌啶和高哌啶氮上未取代但带有--(A2)p--X--(A2)d--Q侧链的新型化学中间体。